North Carolina Medical Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 7, 2025
BACKGROUND
Individuals
with
chronic
pain
often
turn
to
the
health
care
system
for
treatment
and
management
strategies,
but
barriers
access
can
make
this
difficult.
METHODS
We
analyzed
data
from
2018
2019
North
Carolina
Behavioral
Risk
Factor
Surveillance
System
(NC
BRFSS)
surveys
understand
whether
coping
mechanisms
differed
by
specific
barriers,
sex,
race/ethnicity.
assessed
4
barriers:
coverage
barrier
(no
insurance),
provider
personal
doctor/provider),
cost
(not
seeing
a
doctor
in
past
year
due
cost),
checkup
2
years).
RESULTS
Compared
individuals
no
any
used
tied
(e.g.,
prescription
drugs
non-medication
therapies)
less
frequently.
Differences
were
also
observed
sex
Among
or
without
men
reported
using
alcohol
marijuana
other
street
cope
more
frequently
than
women,
while
women
medications
men.
at
least
one
barrier,
Black,
non-Hispanic
therapies
White,
individuals.
LIMITATIONS
The
response
rate
NC
BRFSS
was
low,
though
adjusted
weighting.
limited
available
categories
mechanisms,
we
restricted
race/ethnicity
analyses
CONCLUSIONS
Our
findings
indicate
that
differences
use
of
non-prescription
may
be
interconnected
barriers.
Medicina,
Journal Year:
2024,
Volume and Issue:
60(2), P. 272 - 272
Published: Feb. 4, 2024
Fibromyalgia
is
a
complex
and
often
misunderstood
chronic
pain
disorder.
It
characterized
by
widespread
musculoskeletal
pain,
fatigue,
heightened
sensitivity,
has
evolved
in
diagnostic
criteria
understanding
over
the
years.
Initially
met
with
skepticism,
fibromyalgia
now
recognized
as
global
health
concern
affecting
millions
of
people,
prevalence
transcending
demographic
boundaries.
The
clinical
features
diagnosis
encompass
range
symptoms
beyond
including
sleep
disturbances
cognitive
difficulties.
This
study
emphasizes
importance
comprehensive
evaluation
for
accurate
diagnosis,
considering
shift
from
tender
point
reliance
to
more
holistic
approach.
Etiology
pathophysiology
involve
genetic
predisposition,
neurotransmitter
dysregulation,
central
sensitization,
immune
system
involvement.
Risk
factors
such
gender,
age,
family
history,
comorbid
conditions
contribute
susceptibility.
impact
on
quality
life
profound,
physical
social
aspects,
accompanied
mood
disorders.
Management
approaches
include
pharmacological
interventions,
non-pharmacological
therapies,
lifestyle
modifications,
alternative
treatments.
also
delves
into
emerging
research,
exploring
advances
neurobiological
understanding,
brain
imaging,
markers,
glutamate
modulation,
cannabinoids,
gut
microbiome,
digital
tools
management.
Overall,
this
provides
nuanced
up-to-date
overview
complexities
surrounding
fibromyalgia,
aiming
enhance
support
individuals
grappling
challenging
condition.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(2), P. 403 - 403
Published: Jan. 11, 2024
Limitations
of
pharmaceutical
drugs
and
biologics
for
chronic
diseases
(e.g.,
medication
non-adherence,
adverse
effects,
toxicity,
or
inadequate
efficacy)
can
be
mitigated
by
mobile
medical
apps,
known
as
digital
therapeutics
(DTx).
Authorization
adjunct
DTx
the
US
Food
Drug
Administration
draft
guidelines
on
“prescription
drug
use-related
software”
illustrate
opportunities
to
create
+
combination
therapies,
ultimately
leading
towards
drug–device
products
(DTx
has
a
status
devices).
Digital
interventions
(mobile,
web-based,
virtual
reality,
video
game
applications)
demonstrate
clinically
meaningful
benefits
people
living
with
Alzheimer’s
disease,
dementia,
rheumatoid
arthritis,
cancer,
pain,
epilepsy,
depression,
anxiety.
In
respective
animal
disease
models,
preclinical
studies
environmental
enrichment
other
non-pharmacological
modalities
(physical
activity,
social
interactions,
learning,
music)
surrogates
“active
ingredients”
also
show
improved
outcomes.
this
narrative
review,
we
discuss
how
therapies
impact
translational
research,
discovery
development,
generic
repurposing,
gene
therapies.
Market-driven
incentives
are
illustrated
Humira®
(adalimumab)
facing
“patent-cliff”
competition
cheaper
more
effective
biosimilars
seamlessly
integrated
DTx.
conclusion,
pharma
biotech
companies,
patients,
healthcare
professionals
will
benefit
from
accelerating
integration
pharmacotherapies.
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 434 - 434
Published: Feb. 11, 2025
Background
and
Objectives:
Orofacial
pain
corresponds
to
sensitization
originating
from
the
facial
oral
regions,
often
accompanied
by
diagnostic
complexity
due
a
multitude
of
contributory
factors,
leading
significant
patient
distress
impairment.
Here,
we
have
reviewed
current
mechanistic
pathways
biochemical
aspects
complex
orofacial
pathology,
highlighting
recent
advancements
in
understanding
its
multifactorial
regulation
signaling
thus
providing
holistic
approach
challenging
it.
Materials
Methods:
Studies
were
identified
an
online
search
PubMed
database
without
any
time
range.
Results:
We
discussed
neuron–glia
interactions
glial
cell
activation
terms
immunomodulatory
effects,
metabolism
reprogramming
effects
epigenetic
modulatory
response
comprising
different
factors.
highlighted
fundamental
role
oxidative
stress
affecting
cellular
as
well
machinery,
which
renders
pathology
intricate
multidimensional.
Emerging
research
on
modulation
regulatory
genes
molecular
environmental
factors
is
also
discussed,
alongside
updates
novel
treatment
approaches.
Conclusions:
This
review
deliberates
integrative
perspectives
implications
immune
system,
glucose
metabolism,
lipid
redox
homeostasis
mitochondrial
dysfunction
accommodating
effect
dysregulated
non-coding
RNAs
for
interdisciplinary
at
level,
aiming
improve
outcomes
with
precise
diagnosis
offering
improved
management
treatment.
Global Advances in Integrative Medicine and Health,
Journal Year:
2025,
Volume and Issue:
14
Published: Jan. 1, 2025
Background
The
COVID-19
pandemic
exacerbated
pain
care
inequities
for
low-income
people.
Telehealth
Integrative
Pain
Management
Program
(t-IPMP)
was
developed
to
provide
management
services
patients
in
public
health
clinics
of
the
San
Francisco
Health
Network
(SFHN).
Adapted
from
an
existing
program,
t-IPMP
delivered
multimodal
treatment
via
telehealth
groups
when
in-person
healthcare
restricted.
Objective
This
mixed-methods
study
evaluates
feasibility
and
acceptability
t-IPMP.
Methods
We
conducted
a
single-arm
evaluation
three
cohorts
t-IPMP,
comprising
12
two-hour
weekly
online
sessions
on
education,
mindfulness,
therapeutic
movement,
self-acupressure.
Participants
were
adults
with
chronic
referred
by
SFHN
primary
providers.
baseline
surveys,
three-month
qualitative
interviews
(n
=
15);
participant
observation
per
cohort;
3
focus
20).
Mixed-methods
analysis
included
descriptive
statistics,
pre/post
comparisons
using
t-tests,
codebook
thematic
analysis.
Results
received
107
referrals
52
providers
at
11
clinics,
35%
enrolled.
37)
attended
average
6
sessions.
who
completed
surveys
15)
majority
cisgender
women
(67%)
below-average
wealth
(87%)
diverse
racial
ethnic
identities.
Qualitative
data
highlighted
that
created
supportive
environment
which
fostered
social
connection
reduced
isolation.
Social
support
encouraged
use
new
mind-body
practices
pain.
well
received,
though
some
participants
preferred
interaction.
From
follow
up,
scores
increased
measures
physical
function
(mean
1.9,
95%
CI
0.2-3.6);
global
quality
life
3.8,
1.6-6.0);
self-efficacy
5.3,
0.9-9.7).
Conclusion
Integrative,
through
is
feasible
among
safety
net
patients,
however,
may
not
be
optimal
all.
Findings
indicate
offering
options
participating
either
or
best
address
patient
needs
preferences.
Abstract
Chronic
neuropathic
pain
is
a
debilitating
neuroplastic
disorder
that
notably
impacts
the
quality
of
life
millions
people
worldwide.
This
complex
condition,
encompassing
various
manifestations,
such
as
sciatica,
diabetic
neuropathy
and
postherpetic
neuralgia,
arises
from
nerve
damage
or
malfunctions
in
processing
pathways
involves
biological,
physiological
psychological
processes.
Maladaptive
neuroplasticity,
known
central
sensitization,
plays
critical
role
persistence
chronic
pain.
Current
treatments
for
include
pharmacological
interventions
(for
example,
antidepressants
anticonvulsants),
invasive
procedures
deep
brain
stimulation)
physical
therapies.
However,
these
approaches
often
have
limitations
potential
side
effects.
In
light
challenges,
interest
noninvasive
neuromodulation
techniques
alternatives
complementary
increasing.
These
methods
aim
to
induce
analgesia
while
reversing
maladaptive
plastic
changes,
offering
advantages
over
conventional
practices
methods.
Recent
technological
advancements
spurred
exploration
therapies,
repetitive
transcranial
magnetic
stimulation,
direct
current
stimulation
ultrasound
well
innovative
transformations
into
at
both
preclinical
clinical
levels.
Here
this
review
aims
critically
examine
mechanisms
neuroplasticity
evaluate
efficacy
relief.
By
focusing
on
optimizing
techniques,
we
can
better
assess
their
short-term
long-term
effects,
refine
treatment
variables
ultimately
improve
management.
Fibromyalgia
is
a
complex
and
often
misunderstood
chronic
pain
disorder.
It
characterized
by
widespread
musculoskeletal
pain,
fatigue,
heightened
sensitivity,
has
evolved
in
diag-nostic
criteria
understanding
over
the
years.
Initially
met
with
skepticism,
fibromyalgia
now
recognized
as
global
health
concern
affecting
millions
of
people,
prevalence
trans-cending
demographic
boundaries.
The
clinical
features
diagnosis
encompass
range
symptoms
beyond
including
sleep
disturbances
cognitive
difficulties.
study
emphasizes
importance
comprehensive
evaluation
for
accurate
diagnosis,
considering
shift
from
tender
point
reliance
to
more
holistic
approach.
Etiology
pathophysiology
involve
genetic
predisposition,
neurotransmitter
dysregulation,
central
sensitization,
immune
system
involvement.
Risk
factors
such
gender,
age,
family
history,
comorbid
conditions
contribute
susceptibility.
impact
on
quality
life
profound,
physical
social
aspects,
accompanied
mood
disorders.
Management
approaches
include
pharmacological
interventions,
non-pharmacological
therapies,
lifestyle
modifications,
alternative
treatments.
also
delves
into
emerging
research,
exploring
advances
neurobiological
understanding,
brain
imaging,
markers,
glutamate
modulation,
cannabinoids,
gut
microbiome,
digital
tools
manage-ment.
Overall,
this
provides
nuanced
up-to-date
overview
complexities
sur-rounding
fibromyalgia,
aiming
enhance
support
individuals
grappling
challenging
condition.
Medicina,
Journal Year:
2024,
Volume and Issue:
60(2), P. 285 - 285
Published: Feb. 7, 2024
Chronic
stress
and
chronic
pain
share
neuro-anatomical,
endocrinological,
biological
features.
However,
prepares
the
body
for
challenging
situations
or
mitigates
tissue
damage,
while
is
an
unpleasant
sensation
due
to
nociceptive
receptor
stimulation.
When
chronic,
it
might
lead
allostatic
overload
in
brain
dysregulation
of
physiological
systems
that
are
normally
involved
adapting
environmental
challenges.
Managing
(CP)
neurorehabilitation
presents
a
significant
challenge
healthcare
professionals
researchers,
as
there
no
definitive
effective
solution
these
issues.
Patients
suffering
from
neurological
disorders
often
complain
CP,
which
significantly
reduces
their
quality
life.
The
aim
this
narrative
review
examine
correlation
between
potential
negative
impact
on
rehabilitation
process.
Moreover,
we
described
most
relevant
interventions
used
manage
population.
In
conclusion,
sheds
light
connection
pathway.
Our
results
emphasize
need
tailored
protocols
effectively
pain,
improve
treatment
adherence,
ensure
comprehensive
patient
care.
Chemosensors,
Journal Year:
2024,
Volume and Issue:
12(4), P. 58 - 58
Published: April 8, 2024
Pharmaceutical
opioids
are
intravenously
or
orally
administered
analgesics.
While
they
effective
in
relieving
chronic
and
acute
pain,
their
narrow
window
of
therapeutic
use
contributes
to
the
high
occurrence
abuse.
The
associated
abuse
this
family
drugs
can
be
correlated
increase
dependency,
overdose,
death
users.
negative
effects
extend
beyond
physical
psychological
experienced
by
user
unregulated
synthesis
sale,
which
contribute
socioeconomic
challenges
a
biproduct
global
public
health
epidemic.
From
clinical
point-of-care
applications,
detection
real-time
monitoring
drug
is
critical
fight
decrease
improve
settings.
Chromatographic
separations
chromatography–mass
spectrometry
traditional
methods
opioid
analyses,
but
cost,
long
analysis
time,
absence
portability
highlight
need
for
development
fast,
situ,
analysis,
community
services.
This
review
highlights
recent
electrochemical
optical
(FTIR,
Raman,
colorimetric,
fluorescent)
advances
biosensors
pharmaceutical
illicit
analysis.
Specifically,
an
emphasis
placed
on
metabolites
biological
samples
vitro
cellular
assays
diagnosis
forensic
applications.
prospects
role
sensors,
biosensors,
sensors
promoting
diagnosis,
study,
point-of-care,
services
reduce
harm
also
provided.